4.4 Article

Role of T lymphocytes in hypertension

期刊

CURRENT OPINION IN PHARMACOLOGY
卷 21, 期 -, 页码 14-19

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2014.12.003

关键词

-

资金

  1. National Institutes of Health [DK087893-01]
  2. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development [BX000893-01A2]
  3. Edna and Fred L. Mandel Center for Hypertension and Atherosclerosis Research
  4. American Heart Association [12POST11910012]

向作者/读者索取更多资源

Accumulating evidence indicates that the immune system plays a critical role in the pathogenesis of cardiovascular diseases including hypertension. Mice lacking T lymphocytes are resistant to blood pressure elevation, suggesting a key contribution of T lymphocytes to hypertension. However, the individual T cell subsets, including CDS+, T(h)1, T(h)17, and T regulatory T cells have shown widely discrepant effects on blood pressure and target organ damage in this disorder. Moreover, the activation state of a T lymphocyte population exerts considerable influence over its role in hypertension. In turn, activated T cells regulate blood pressure through the elaboration of reactive oxygen species and vasoactive cytokines, altering the inflammatory milieu in the vascular wall and the kidney. Recent GWAS studies similarly point to a role for T lymphocytes in human hypertension.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据